In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other pharmaceutical stocks. Almost no other industry goes as far as the phrase "defensive" as the ...

In a report released today, Geoff Meacham from Citi maintained a Hold rating on Pfizer (PFE – Research Report), with a price target of $27.00. The company’s shares closed yesterday at $24.54.

Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy ...

Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy ...

1 NEW YORK, March 18, 2025--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EDT on ...

PlayStation is now doubling down on that market by making the PS5 Pro even more of a technological powerhouse by implementing something more like AMD’s recent FSR 4 technology in 2026.

I last covered Pfizer Inc. (PFE) stock early this year on January 8, 2025. To be more explicit, that article was titled “Dividend Roundup: Why I Prefer Johnson & Johnson Over Pfizer”.

Another positive sign is that PFE demonstrated a record free cash flow level of almost $8 billion in Q4 2024, which was the highest since the fourth quarter of FY2022. This is crucial because one ...